Australia's Firebrick Pharma climbs to 7-month high on US product launch

Firebrick Pharma

17/04/2024 03:48

** Shares of Firebrick Pharma  FRE.AX  rise as much as
115.7% to A$0.110, their highest since Sept 13, 2023
    ** Stock posts its biggest intraday percentage gain since
Nov 15, 2023
    ** The pharmaceutical co launches its antiseptic nasal spray
Nasodine in the U.S.
    ** Nearly 6.8 mln shares change hands, compared with the
30-day average volume of 111,635
    ** Firebrick stock up 2% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))